18 Biggest Mid-Day Losers For Wednesday

  • Alliqua Biomedical Inc ALQA shares tumbled 31.2 percent to $0.430. Alliqua BioMedical priced its 9.375 million share offering at $0.40 per share.
  • Atossa Genetics Inc ATOS shares dipped 26.1 percent to $0.806 after the company reported the pricing of its $4,000,000 public offering.
  • Ritter Pharmaceuticals Inc RTTR shares dipped 22.8 percent to $1.51 after the company reported topline results from its Ph2b/3 study for lactose intolerance treatment RP-G28.
  • New Concept Energy, Inc. GBR shares fell 21.9 percent to $1.68.
  • Diffusion Pharmaceuticals Inc DFFN shares dropped 21.1 percent to $3.93.
  • Sunshine Heart Inc SSH declined 16.9 percent to $1.92. Sunshine Heart reported that it has received Nasdaq listing extension.
  • Highpower International Inc HPJ shares fell 16.3 percent to $4.10.
  • Catalyst Biosciences Inc CBIO shares tumbled 15.1 percent to $12.75 after surging 179.52 percent on Tuesday.
  • Pernix Therapeutics Holdings Inc PTX dropped 14.2 percent to $3.48. Pernix Therapeutics reported a Q4 loss of $86.1 million.
  • Quorum Health Corp QHC shares declined 13.5 percent to $5.51 after the company posted disappointing Q4 results.
  • Takung Art Co Ltd TKAT dropped 13 percent to $8.30. Takung is expected to report 2016 financial results on March 29.
  • Viewray Inc VRAY shares fell 6 percent to $8.12 after declining 8.76 percent on Tuesday.
  • MoSys Inc. MOSY shares declined 5.3 percent to $2.32 as the company posted a wider-than-expected quarterly loss.
  • USG Corporation USG dropped 4.5 percent to $32.22. Macquarie downgraded USG from Outperform to Neutral.
  • F5 Networks, Inc. FFIV fell 4 percent to $141.29. Deutsche Bank downgraded F5 Networks from Hold to Sell.
  • Skechers USA Inc SKX shares declined 3.1 percent to $29.05. Susquehanna downgraded Skechers from Positive to Negative.
  • Depomed Inc DEPO shares fell 3 percent to $13.81. Depomed reported a cooperation agreement with Starboard Value LP. The company also issued a weak Q1 sales forecast.
  • Dave & Buster's Entertainment, Inc. PLAY fell 2 percent to $60.96. Dave & Buster's reported better-than-expected earnings for its fourth quarter, but issued cautious outlook for 2017.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!